Discrepancies in Skin Cancer Screening Reporting Among Patients, Primary Care Physicians, and Patient Medical Records

Cutis. 2022 Aug;110(2):92-97. doi: 10.12788/cutis.0590.

Abstract

Skin cancer incidence in the United States has risen rapidly in recent decades, underscoring the need for accessible and effective prevention practices. The full-body skin examination (FBSE) is the quintessential tool for secondary skin cancer prevention, but the US Preventive Services Task Force (USPSTF) states there is insufficient evidence to recommend the examination for the general or at-risk population. Variable performance of FBSEs among primary care providers (PCPs) is a barrier to accurate studies, and variability in measurement of that performance can be a major impediment to assessment of FBSEs in practice. To better understand the degree of variability, we performed a multicenter, cross-sectional study of FBSEs reported among 53 PCPs and 3343 patients. The results highlight the need for standardization of FBSEs and more rigorous criteria for skin cancer screening.

Publication types

  • Multicenter Study

MeSH terms

  • Cross-Sectional Studies
  • Early Detection of Cancer
  • Humans
  • Mass Screening
  • Medical Records
  • Physicians, Primary Care*
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / prevention & control
  • United States / epidemiology